KeyBanc lowered the firm’s price target on Eastman Chemical (EMN) to $79 from $93 and keeps an Overweight rating on the shares. The firm says that as disappointing as Eastman’s Q2 was, it wouldn’t have expected a 19% stock decline. While KeyBanc is revising 2025 EPS 18% lower, the firm judges about half of this revision is temporary in nature.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMN: